HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
Feinstein Institutes Bioelectronic Medicine Scientists Develop First-of-its-Kind Wireless Neuromodulation Device for Research
“Neuromodulation and bioelectronic medicine hold the potential to treat a variety of diseases without the use of traditional pharmaceuticals and their potential side effects, however, scaling devices to the size needed for studies in mice has been very challenging,” said Timir Datta, PhD, assistant professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes and senior author on the paper.
Sensydia Receives FDA Breakthrough Device Designation for CPSTM Non-Invasive Cardiac Monitoring Device
Through its ultra-sensitive biosensors, CPS acquires heart sound data and applies machine learning to compute multiple hemodynamic measurements, delivering all in one comprehensive report via the CPS iPad app.
2022 Catalyst Award Winners
Catalyst Awards Conference and Dinner is on March 17, 2022. Winners will be recognized for accelerating opportunities for women and increasing women’s representation and inclusion across intersections of identity within their organizations.
GORE® CARDIOFORM Septal Occluder Marks 10 Years of Improving Lives
The device is backed by the Gore REDUCE Clinical Study, a groundbreaking study in which 664 patients were enrolled to evaluate whether PFO closure with the GORE CARDIOFORM Septal Occluder or the GORE® HELEX® Septal Occluder plus antiplatelet therapy significantly reduces the risk of stroke compared to antiplatelet therapy alone.
SOLTIVE™ SuperPulsed Laser System Shortens Kidney Stone Procedure Time
The two abstracts noting these findings were published in the September edition of The Journal of Urology.
Alizea Bluetooth Pacemaker Receives Approval in Japan Reports MicroPort CRM
Benoît Clinchamps, President of MicroPort CRM, noted, "We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions.
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
Scott R. Ward, Chairman, President and CEO, said, “The development of an IVL system for the treatment of coronary and peripheral artery disease will uniquely position CSI to provide the right device, for the right lesion, for all physicians.
iSTAR Medical Shows Initial Positive Progress of US STAR-V Trial for MINIject
Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the US. Positive feedback from world-leading glaucoma surgeons involved in the trial. MINIject is the only commercially available MIGS device targeting the supraciliary space. Commercial rollout continues following European approval in 2021
Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility Study
“The Japanese market is ideal for Impella 5.5 with SmartAssist because the technology provides minimally invasive, longer-term unloading support, enabling native heart recovery in a country that is more resistant to invasive sternotomies and heart transplants,” said Michael R. Minogue, Abiomed’s Chairman, President and Chief Executive Officer.